The Department of Justice (DoJ) recovered a total of $694.5 million in settlements from a device manufacturer and two pharmaceutical companies during FY 2008.

MedPac, the congressional advisory commission on Medicare, has endorsed stringent transparency rules for drug, device and biologics manufacturers, including detailed reporting on drug samples with the aim of facilitating targeted counter-detailing.

Data analyzing Zyrtec's crossover found many patients didn't follow the drug over the counter, according to a Nielsen-Wolters Kluwer Health report.

Fight! Fight! Two leading congressional critics of the pharma industry—Rep. Henry Waxman (D-CA) and John Dingell (D-MI)—are at odds over a committee chairmanship.

The Medical Advertising Hall of Fame announced its 2009 inductees: LM&P founder Ron Pantello, Dorland's Harry Sweeney and Interbrand Wood Healthcare's David Wood.

GlaxoSmithKline (GSK) announced that it will reduce its sales personnel by 12% to 7,500 down from 8,500.

Over 60 million adults in the US are using social media applications for healthcare online, and many are speaking directly about products, according to a new Manhattan Research report.

Forty-four percent of Sermo physicians polled found Senator McCain's healthcare plan to be "beneficial to the country," compared with 30% that said Senator Obama's is beneficial.

The Supreme Court appeared headed for another close decision in today's hearing of Wyeth vs. Levine, a case seen as a key test of whether FDA labeling pre-empts "failure to warn" lawsuits against drug companies in state courts.

Career staffers at the FDA objected to new drug labeling regulations that favor pre-emption of state liability lawsuits, according to a report from Rep. Henry Waxman's Committee on Oversight and Government Reform.